Navigation Links
Anti-biotech groups obstruct forest biotechnology
Date:6/30/2009

ipate in contentious and time-consuming debates where "the quality of scientific discussions tend to be extremely low and highly combative."

The researchers believe that major changes in the structure and interpretation of the treaty are required to prevent its continued misuse in ways that they argue "is clearly against its original spirit and intent."


'/>"/>

Contact: Steven Strauss
steve.strauss@oregonstate.edu
541-760-7357
Oregon State University
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Business, scientific, higher education groups laud President Obamas commitment to science
2. Disabled and other vulnerable groups more susceptible to terrorism fears
3. Caltech researchers get first look at how groups of cells coordinate their movements
4. Gender biases in leadership selection during competitions within and between groups
5. Nations and conservation groups seek plan to protect Ghost of the Himalayas
6. Madagascars tortoises are crawling toward extinction, groups say
7. Environmental groups call for increased protection of coral reefs
8. Varying prevalence among ethnic groups of gene mutation that increases risk of breast cancer
9. Tree of life for flowering plants reveals relationships among major groups
10. UF botanists: Flowering plants evolved very quickly into 5 groups
11. African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...an has received more than $10 million in research ...ederal stimulus program, bringing thetotal amount ...$23 million. Thirty-three projects achieved stimu...o weather. , "The university has thoughtfully un... scholarly excellence to federal agency priorities...
(Date:11/4/2009)...re/ -- What,s the cost of saving a teenage life? W...ing from prescription medication abuse, there,s no... may be unaware that the lock-boxes they,ve instal...g timebomb of prescription drugs. That,s why MEDNE...l supplies, has formed an exclusive partnership wi...
(Date:11/4/2009)...wswire/ -- GenVault Corporation (Carlsbad, CA) tod...joined its Board of Directors. Dr. Brody, the Irw..., is an acclaimed physician-scientist and universi...r. Brody served as president of The Johns Hopkins ...y of Engineering and the Institute of Medicine, an...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Hormone therapy may confer more aggressive properties to prostate tumors 48453 1Drugs against winter vomiting disease one step closer 48451 1Drugs against winter vomiting disease one step closer 48451 2New Jefferson study may redefine how a chronic auto immune disease is diagnosed 48449 1New Jefferson study may redefine how a chronic auto immune disease is diagnosed 48449 2
...immune system cells go through a laboratory versio...against HIV, believe University of Pittsburgh rese... development of a novel therapeutic vaccine loaded...hich have been galvanized to rally other cells of ...that individual. , At the XVI International AIDS ...
... the Harvard Department of Ophthalmology,s Schepen... Ear Infirmary (MEEI) are the first to learn why t... blood vessels--a unique phenomenon that makes vis... unexpected presence of large amounts of the prote...eptor-3) on the top epithelial layer of normal hea...
...e has its place and role in the oceans ?even the s... lead to more accurate models of ocean change. , ...que biological niche for most animals and plants ?...dolphin. , Bacteria instead have been relegated ... which few species are considered unique, said Jed...
Other Biology News:T cells activated to fight HIV basis for dendritic cell therapeutic vaccine 2T cells activated to fight HIV basis for dendritic cell therapeutic vaccine 3Scientists discover why cornea is transparent and free of blood vessels, allowing vision 2Scientists discover why cornea is transparent and free of blood vessels, allowing vision 3Bacteria can help predict ocean change 2
(Date:11/4/2009)...ch will be presented on November 19 and is of inte...y processing, will deal with the application of th...micro scale flow chemistry equipment. Professor L...ized with several prestigious prizes and awards, i... , Columbia, MD (PRWEB) N...
(Date:11/4/2009)...irstCall/ -- Star Scientific, Inc . (Nasdaq: S...troduce the CigRx(TM) nutraceutical product develo... for worldwide marketing and sales in partnership ...Ventiv Health offers a complete range of commercia...lifecycle, in a range of healthcare categories tha...
(Date:11/4/2009)...e-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR...ird quarter ended September 30, 2009. ,, Net l...ved to $31.0 million or $0.33 per share, as compar...re in the third quarter of 2008. ,, Nektar c...iciencies as compared to a year ago. Total operat...
(Date:11/4/2009)...ire/ -- Health Robotics today announced,the worldw...rkflow Engine at,the American Society of Health-Sy...n Las Vegas. With the availability of the i.v.SOFT...t and only company in the world to provide a,total... process control and,patient safety in the I.V. Ro...
Breaking Biology Technology:Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas 2Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas 3
...SAN DIEGO, March 2 BioMed Realty Trust, Inc. (NYS...cutive management will present at the Citi 2009 Gl... approximately 9:05 a.m. Eastern Standard Time on ...ll be open to all investors by calling 719.785.559...ioMed Realty Trust , BioMed Realty Trust, Inc. is...
..., Innovative B.C. Technology Promises to Revolu...ER, March 2 /PRNewswire-FirstCall/ - EnWave Corpor...ay announced that it has completed the first sale ...uipment to CAL-SAN Enterprises, Ltd. of Richmond, ...producers. With this sale, EnWave has proven that ...
... EXTON, Pa., March 2 Morphotek(R), Inc., a sub...ay announced that it has commenced a,multi-centere...ody in,mesothelioma. The study will evaluate MORAb...isplatinum, as a first-line treatment for patients... the study is to assess the efficacy of MORAb-009,...
Other Biology Technology:EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology 2EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology 3EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology 4Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 2Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 3
Mouse Anti-Human E1A (adenovirus early region 1) Monoclonal Antibody, Unconjugated, Clone M73 from Exalpha Biologicals, Inc.
Blocking Reagent, TBS with 1% BSA from Bethyl Laboratories
Anti-Presenilin-1, N-terminus Polyclonal Antibody, Unconjugated from CHEMICON
RayBio Human Chemokine Antibody Array I & 1.1 Service from Raybiotech, Inc.
Biology Products: